XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 898,000 $ 1,701,000
Marketable investments 1,349,000 2,276,000
Other Receivables 19,000
Prepaid expenses and other current assets 318,000 199,000
Total current assets 2,584,000 4,176,000
Property and equipment, net 98,000 108,000
Right of use asset, net 554,000 618,000
Patent and trademark rights, net 2,267,000 2,594,000
Other assets 745,000 1,112,000
Total assets 6,248,000 8,608,000
Current liabilities:    
Accounts payable 6,944,000 6,383,000
Accrued expenses 639,000 606,000
Current portion of operating lease liability 234,000 239,000
Current portion of note payable, net 1,950,000 2,307,000
Total current liabilities 9,767,000 9,535,000
Long-term liabilities:    
Operating lease liability 338,000 395,000
Total liabilities 10,105,000 9,930,000
Commitments and contingencies (Notes 13 and 14)
Stockholders’ deficit:    
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 72,290,030 and 65,526,320 as of March 31, 2025 and December 31, 2024, respectively 72,000 66,000
Additional paid-in capital 426,604,000 425,440,000
Accumulated deficit (430,533,000) (426,828,000)
Total stockholders’ deficit (3,857,000) (1,322,000)
Total liabilities and stockholders’ deficit 6,248,000 8,608,000
Series A Junior Participating Preferred Stock [Member]    
Stockholders’ deficit:    
Preferred Stock, value
Series B Convertible Preferred Stock [Member]    
Stockholders’ deficit:    
Preferred Stock, value